Oxford BioDynamics (LON:OBD) Stock Price Crosses Below Fifty Day Moving Average – What’s Next?

Oxford BioDynamics Plc (LON:OBD) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 0.43 and traded as low as GBX 0.28. Oxford BioDynamics shares last traded at GBX 0.29, with a volume of 45,798,555 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Shore Capital reaffirmed a “house stock” rating on shares of Oxford BioDynamics in a research report on Wednesday, October 8th.

Oxford BioDynamics Stock Performance

The company has a debt-to-equity ratio of 370.22, a current ratio of 0.68 and a quick ratio of 2.80. The company has a fifty day moving average price of GBX 0.43 and a two-hundred day moving average price of GBX 0.42. The firm has a market cap of £5.50 million, a price-to-earnings ratio of -0.10 and a beta of 0.42.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.